| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.693.412 | 2.338.324 | 2.499.512 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 2.758.843 | 2.351.889 | 2.515.572 | 44.083 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 2.632.518 | 2.188.350 | 2.304.584 | 30.289 | 9.205 | 140 | 0 | 0 | 0 | 9.662 |
| Gross Profit/Loss - EUR | 126.325 | 163.540 | 210.988 | 13.793 | -9.205 | -140 | 0 | 0 | 0 | -9.662 |
| Net Profit/Loss - EUR | 109.302 | 141.768 | 181.333 | 11.587 | -9.205 | -140 | 0 | 0 | 0 | -9.662 |
| Employees | 84 | 77 | 73 | 2 | 2 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Gramfarin Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 44.247 | 30.036 | 16.349 | -4.633 | -4.543 | -4.457 | -4.358 | -4.372 | -4.358 | 0 |
| Current Assets | 209.865 | 313.150 | 287.353 | 210.542 | 278.661 | 274.083 | 268.005 | 268.836 | 268.021 | 240.165 |
| Inventories | 0 | 255 | 800 | 786 | 770 | 756 | 739 | 741 | 739 | 735 |
| Receivables | 193.661 | 244.949 | 253.440 | 184.011 | 257.996 | 253.860 | 248.231 | 249.001 | 248.246 | 230.247 |
| Cash | 16.204 | 67.945 | 33.113 | 25.745 | 19.895 | 19.467 | 19.035 | 19.094 | 19.036 | 9.183 |
| Shareholders Funds | 76.404 | 141.963 | 181.562 | 189.817 | 176.936 | 173.442 | 169.596 | 170.122 | 169.606 | 158.996 |
| Social Capital | 157 | 156 | 153 | 150 | 148 | 145 | 142 | 142 | 142 | 141 |
| Debts | 177.708 | 201.222 | 122.140 | 16.092 | 97.181 | 96.184 | 94.051 | 94.342 | 94.056 | 81.169 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7820 - 7820" | |||||||||
| CAEN Financial Year |
7820
|
|||||||||
Comments - Gramfarin Srl